This protocol is judged by an institutional critique board, an unbiased group that reviews any medical trials involving humans. If a study requires a Agenda I drug, after the board approves the protocol as moral, the researchers should submit an application for an investigational new drug (IND) quantity through the FDA.“It’s imperative that yo